North America held largest share of Thrombectomy Devices Market. Growth of this Asia-Pacific market attributed to presence of a large patient population for target diseases, rising awareness among surgeons related to benefits offered by thrombectomy devices, increasing healthcare expenditure, & rising adoption of these devices due to their decreasing costs.
The global thrombectomy devices market estimated to reach USD 1.45 Billion by 2022; growing at a CAGR of 6.7% during forecast period. Growing target patient population, ongoing technological advancements, favorable medical reimbursements, rising demand for minimally invasive thrombectomy procedures, & increasing healthcare expenditure across emerging markets are some key factors propelling growth of this market.
Complete Report on Thrombectomy Devices Marketspread across 174 Pages, Profiling 12 Companies and Supported with 67 Tables and 75 Figures is now available at http://www.reportsnreports.com/reports/975809-thrombectomy-devices-market-by-type-hydrodynamic-ultrasound-aspiration-mechanical-thrombectomy-application-cardiovascular-peripheral-neurovascular-end-user-hospitals-surgical-centers-ambulatory-academ-ts-to-2022.html .
In thrombectomy devices market report, has been segmented on basis of type, application, end user, and region. This large market share mainly attributed to factors like increasing prevalence of cardiovascular diseases across major markets, procedural benefits offered by mechanical thrombectomy in cardiac surgeries, higher prevalence of thrombotic diseases among geriatric individuals, and growing preference of surgeons for image-guided & minimally invasive cardiac surgeries.
- Healthcare service providers (hospitals and surgical centers)
- Non-government organizations
- Government regulatory authorities
- Research laboratories and academic institutes
- Clinical research organizations (CROs)
- Research and development companies
- Market research and consulting firms
On basis of type, thrombectomy devices market is segmented into aspiration, mechanical/fragmentation, rheolytic/hydrodynamic, and ultrasonic thrombectomy devices. Based on type, the market is segmented into aspiration, mechanical, rheolytic, and ultrasonic thrombectomy devices. The ultrasonic thrombectomy devices segment is poised to be the fastest growing during the forecast period.
Click Now for PDF Sample Download of this Study Report
The thrombectomy devices report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market and in turn help firms garner greater shares. Firms purchasing the report could use any one or a combination of the below-mentioned five strategies for strengthening their market shares.
Medtronic plc (Ireland), Boston Scientific Corporation (U.S.), Johnson & Johnson (U.S.), Terumo Corporation (Japan), Penumbra, Inc. (U.S.), Spectranetics Corporation (U.S.), Edwards Lifesciences Corporation (U.S.), Argon Medical Devices, Inc. (U.S.), and Teleflex Incorporated (U.S.), were few other key players operating in the market.
Connect for More Details for Discount and More Information “Thrombectomy Devices Market by Type (Hydrodynamic, Ultrasound, Aspiration, Mechanical Thrombectomy), Application (Cardiovascular, Peripheral, Neurovascular), End User (Hospitals, Surgical Centers, Ambulatory, Academia, CROs) – Global Forecasts to 2022” report @ http://www.reportsnreports.com/contacts/discount.aspx?name=975809
Growing demand for ultrasonic thrombectomy devices market can primarily be attributed to factors such as rising adoption of ultrasonic thrombectomy products by medical professionals, higher therapeutic efficacy for treatment of deep vein thrombosis and pulmonary embolism, and its affordability.
On basis of application, global market is segmented into cardiovascular, peripheral vascular, and neurovascular applications. Peripheral vascular segment is expected to be fastest growing in market during forecast period.